RespireRx Pharmaceuticals Inc (fka RSPI)

[bladerunner1717]

Neuro,

Besides boilerplate references to "confidentiality" and such (and yes, SGP is in charge of the trials, blah, blah, blah), is there any reason that you can think of that COR never mentions verbally in these public forums anything having to do with the partnership with SGP? Specifically, one might have thought that Stoll would at least mention that SGP had taken a COR Ampakine into trials in ADHD. And, btw, it's hard for me to believe that SGP would take a COR Ampakine into ADHD without seeing something pretty promising in schizo and/or depression. Do you agree? Furthermore, doesn't it make sense that if SGP has really promising results in ADHD, they would want to lock up some rights to COR's later patent expiration low-impacts?


Bladerunner